Daniil Gataulin's Stock Ratings

Chardan Capital Analyst

Daniil Gataulin is an analyst at Chardan Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024

Overall Average Return

11.7%

Smart Score

53%

Overall Average Return Percentile

66th

Number of Ratings

39
Buy NowGet Alert
06/28/2024EYPTBuy Now
EyePoint Pharmaceuticals
$8.68222.58%$28 → $28MaintainsBuyGet Alert
06/11/2024OCSBuy Now
Oculis Holding
$12.36142.72%$30 → $30ReiteratesBuy → BuyGet Alert
06/06/2024CGTXBuy Now
Cognition Therapeutics
$1.91475.92% → $11Initiates → BuyGet Alert
05/15/2024OCGNBuy Now
Ocugen
$1.73189.02%$5 → $5MaintainsBuyGet Alert
05/07/2024EYPTBuy Now
EyePoint Pharmaceuticals
$8.68222.58%$39 → $28MaintainsBuyGet Alert
04/22/2024OCGNBuy Now
Ocugen
$1.73189.02%$4 → $5MaintainsBuyGet Alert
03/19/2024OCSBuy Now
Oculis Holding
$12.36142.72%—MaintainsBuyGet Alert
03/19/2024ADVMBuy Now
Adverum Biotechnologies
$7.18-44.29% → $40ReiteratesBuy → BuyGet Alert
03/07/2024PPBTBuy Now
Purple Biotech
$0.372882.65%$11 → $11MaintainsBuyGet Alert
03/07/2024RGNXBuy Now
Regenxbio
$10.63389.18%$52 → $52MaintainsBuyGet Alert
02/15/2024OTLKBuy Now
Outlook Therapeutics
$7.86-61.83% → $60UpgradeNeutral → BuyGet Alert
12/05/2023OCSBuy Now
Oculis Holding
$12.36142.72% → $30Initiates → BuyGet Alert
08/31/2023OTLKBuy Now
Outlook Therapeutics
$7.86——DowngradeBuy → NeutralGet Alert
08/15/2023OTLKBuy Now
Outlook Therapeutics
$7.8627.23% → $200ReiteratesBuy → BuyGet Alert
08/11/2023ADVMBuy Now
Adverum Biotechnologies
$7.18-44.29%$20 → $40UpgradeNeutral → BuyGet Alert
08/03/2023RGNXBuy Now
Regenxbio
$10.63417.4% → $55Reiterates → BuyGet Alert
08/03/2023EYPTBuy Now
EyePoint Pharmaceuticals
$8.68153.46% → $22ReiteratesBuy → BuyGet Alert
07/25/2023KODBuy Now
Kodiak Sciences
$2.46——DowngradeBuy → NeutralGet Alert
05/19/2023EYPTBuy Now
EyePoint Pharmaceuticals
$8.68153.46%$21 → $22MaintainsBuyGet Alert
05/16/2023OTLKBuy Now
Outlook Therapeutics
$7.8627.23% → $200ReiteratesBuy → BuyGet Alert
05/08/2023OCGNBuy Now
Ocugen
$1.73131.21%$3.5 → $4MaintainsBuyGet Alert
05/05/2023RGNXBuy Now
Regenxbio
$10.63417.4%$61 → $55MaintainsBuyGet Alert
04/14/2023OCGNBuy Now
Ocugen
$1.73102.31% → $3.5MaintainsBuyGet Alert
03/03/2023EYPTBuy Now
EyePoint Pharmaceuticals
$8.68141.94% → $21Reiterates → BuyGet Alert
03/02/2023RGNXBuy Now
Regenxbio
$10.63473.85% → $61Reiterates → BuyGet Alert
03/01/2023OCGNBuy Now
Ocugen
$1.73102.31% → $3.5UpgradeNeutral → BuyGet Alert
02/15/2023FREQBuy Now
Frequency Therapeutics
———DowngradeBuy → NeutralGet Alert
12/08/2022FREQBuy Now
Frequency Therapeutics
—— → $350Initiates → BuyGet Alert
11/11/2022ADVMBuy Now
Adverum Biotechnologies
$7.18-72.14%$25 → $20MaintainsNeutralGet Alert
11/08/2022OYSTBuy Now
Oyster Point Pharma
——$22 → $13DowngradeBuy → NeutralGet Alert
11/04/2022RGNXBuy Now
Regenxbio
$10.63473.85%$70 → $61MaintainsBuyGet Alert
09/28/2022AGTCBuy Now
Applied Genetic
——$5 → $3MaintainsBuyGet Alert
09/13/2022OTLKBuy Now
Outlook Therapeutics
$7.8627.23% → $200Initiates → BuyGet Alert
08/12/2022ADVMBuy Now
Adverum Biotechnologies
$7.18-65.18%$30 → $25MaintainsNeutralGet Alert
08/11/2022OYSTBuy Now
Oyster Point Pharma
—— → $22Initiates → BuyGet Alert
08/10/2022KODBuy Now
Kodiak Sciences
$2.46631.71%$19 → $18MaintainsBuyGet Alert
07/07/2022EYPTBuy Now
EyePoint Pharmaceuticals
$8.68141.94% → $21Initiates → BuyGet Alert
05/18/2022AGTCBuy Now
Applied Genetic
——$8 → $5MaintainsBuyGet Alert
05/05/2022RGNXBuy Now
Regenxbio
$10.63558.51%$76 → $70MaintainsBuyGet Alert